<DOC>
	<DOCNO>NCT01285492</DOCNO>
	<brief_summary>This 52-week treatment , multi-center , randomize , open label , parallel group study assess long term safety tolerability once-daily QVA149 ( indacaterol NVA237 ( [ glycopyrronium bromide ] ) use tiotropium active control Japanese patient moderate severe chronic obstructive pulmonary disease ( COPD ) .</brief_summary>
	<brief_title>Long Term Safety Tolerability QVA149 Versus Tiotropium Japanese Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Patients moderate severe stable COPD ( Stage II Stage III ) accord Global Initiative Chronic Obstructive Lung Disease ( GOLD ) Guidelines 2008 . Current exsmokers smoke history least 10 pack year . ( Ten pack year define 20 cigarette day 10 year , 10 cigarette day 20 year etc . ) Patients postbronchodilator force expiratory volume one second ( FEV1 ) â‰¥30 % &lt; 80 % predict normal , postbronchodilator FEV1/forced vital capacity ( FVC ) &lt; 0.7 Visit 2 . Pregnant woman nurse mother woman childbearing potential use acceptable method contraception Patients require long term oxygen therapy Patients low respiratory tract infection within 4 week prior Visit 1 Patients concomitant pulmonary disease Patients history asthma Any patient history malignancy organ system ( include lung cancer ) , treat untreated , within past 5 year Patients history certain cardiovascular comorbid condition Patients known history diagnosis alpha1 antitrypsin deficiency Patients active phase supervise pulmonary rehabilitation program Patients contraindicate treatment , history reactions/ hypersensitivity anticholinergic agent , long short act beta2 agonist , sympathomimetic amine Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>QVA149</keyword>
	<keyword>NVA237</keyword>
	<keyword>indacaterol</keyword>
	<keyword>combination bronchodilator</keyword>
</DOC>